Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
about
The Economic Costs of Type 2 Diabetes: A Global Systematic ReviewFamilial risks for type 2 diabetes in Sweden.Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertensionLiving with diabetes: rationale, study design and baseline characteristics for an Australian prospective cohort studyAutomated data extraction--a feasible way to construct patient registers of primary care utilization.Cost-utility analysis of glucagon-like Peptide-1 agonists compared with dipeptidyl peptidase-4 inhibitors or neutral protamine hagedorn Basal insulin as add-on to metformin in type 2 diabetes in swedenRisk equations for the development of worsened glucose status and type 2 diabetes mellitus in a Swedish intervention program.Risk of cancer following hospitalization for type 2 diabetes.Subsequent Type 2 Diabetes in Patients with Autoimmune DiseaseAnnual Medical Costs of Swedish Patients with Type 2 Diabetes Before and After Insulin Initiation.Risk of mortality and recurrent cardiovascular events in patients with acute coronary syndromes on high intensity statin treatment.The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program.Hospital comparison of stroke care in Sweden: a register-based studyThe impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.Use of healthcare resources after gestational diabetes mellitus: a longitudinal case-control analysis.Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014.
P2860
Q28087120-C6682928-1CD4-4D6D-BB65-BF45077D8B02Q33602186-AA0B5C56-8B26-4C72-9E7B-464B2A17AB59Q33710477-15777506-22D6-48C4-9C26-CF0185B00FCDQ34118121-64B03239-2F00-4B30-9DD6-FD0FF6B1AFDBQ34159286-94093098-4770-4423-ADDF-D52DAF87C9A6Q34726534-77BB01FB-A864-4CF9-A60C-D0B1FFA98A79Q35087315-EE12D3C9-4A02-4221-AC55-B14D1F8CF852Q35584115-444DB02F-EE73-4DE2-9D42-4E0C5452B8CBQ36039522-F732E6C2-A195-4117-B790-05EB420865BEQ37468464-045B1121-D5D7-4FEE-9542-41EAA3F33B9AQ37731877-DCEF2CC0-61D5-4803-BF1A-AF191C3E0514Q38321172-BE495ECF-BD17-440E-A0C8-40F21AAC1DA8Q40443814-438EFBA0-0C78-440F-9595-27052A395B82Q41930206-6FBA74A3-2AA1-4A7B-9BDE-9C1E1F819BC1Q42623432-ED6A1C2F-CC4A-4276-B933-AB5C8698B579Q45332516-EEBE9555-4A5C-4F53-9597-F2C8970BF9EEQ48097169-2F7AF0AD-37E6-494E-9D04-FB04AC705927Q53832210-3792A8A7-455C-4E83-B589-CDB0001D3315
P2860
Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Resource use and costs of type ...... opulation-based register data.
@ast
Resource use and costs of type ...... opulation-based register data.
@en
type
label
Resource use and costs of type ...... opulation-based register data.
@ast
Resource use and costs of type ...... opulation-based register data.
@en
prefLabel
Resource use and costs of type ...... opulation-based register data.
@ast
Resource use and costs of type ...... opulation-based register data.
@en
P2093
P1476
Resource use and costs of type ...... opulation-based register data.
@en
P2093
A Ringborg
J Stålhammar
M Martinell
P304
P356
10.1111/J.1742-1241.2008.01716.X
P577
2008-03-17T00:00:00Z